ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1460 National Cancer Institute Html en Adjustment to Cancer: Anxiety and Distress (PDQ®)–Health Professional Version Expert-reviewed information summary about the difficult emotional responses many cancer patients experience. This summary focuses on normal adjustment issues, psychosocial distress, and adjustment disorders.
cancer treatment0.348496
adjustment disorders0.377426
newly diagnosed cancer0.338474
palliative care specialist0.336033
emotional distress0.481089
recurrent breast cancer0.355658
ambulatory cancer patients0.342576
psychological distress0.361971
Japanese cancer patients0.3428
Cancer Network Distress0.42624
early-stage breast cancer0.450601
adult cancer patients0.342011
posttreatment distress0.33562
health care professionals0.348864
normal adjustment0.438186
adolescent cancer patients0.355821
social support0.338806
breast cancer patients0.4182
patients0.62456
cancer patients0.6025
normal adjustment issues0.349617
cancer diagnosis0.33963
breast cancer survivors0.37097
mental disorders0.352228
psychosocial distress0.487249
adjustment0.494267
women0.328737
distress0.685449
psychosocial assessment0.364194
study0.349859
distress scores0.331169
stage breast cancer0.326706
breast cancer diagnosis0.330404
palliative care0.44264
cancer-related life events0.334421
life0.404419
posttreatment cancer-related distress0.396788
general distress indices0.342126
primary oncology team0.360914
diagnostic criteria0.346926
psychosocial assessment interview0.338281
Community Cancer Care0.328482
advanced cancer0.337588
breast cancer0.994793
mental disorder0.347463
psychological well-being0.349655
Psychosocial Distress section0.403402
general distress0.349587
major depressive disorder0.329474
CLICK HERE
1590 National Cancer Institute Html en Adjustment to Cancer: Anxiety and Distress (PDQ®)–Patient Version Expert-reviewed information summary about the difficult emotional responses many cancer patients experience. This summary focuses on normal adjustment issues, psychosocial distress, and adjustment disorders.
cancer treatment0.390955
mental health0.376414
emotional distress0.342467
mild anxiety0.297125
Anxiety disorder—A condition0.322854
long-term cancer survivors0.290225
following PDQ summaries0.289376
PDQ cancer information0.401693
clinical trial search0.290488
clinical trials0.374063
cancer information summary0.360243
normal adjustment0.315173
Cancer education sessions0.292812
patients0.858745
cancer diagnosis0.420677
mental health problem0.344798
symptoms0.369957
anxiety0.674027
NCI PDQ cancer0.318604
cancer survivors0.307582
anxiety disorder0.421462
great anxiety0.289049
problems0.310639
distress0.498316
treatment0.584321
cancer prevention0.287279
NCI-supported cancer0.289072
palliative care0.307485
Cancer Information Service0.302564
life0.319995
generalized anxiety disorder0.307665
cancer patients0.396085
National Cancer Institute0.357347
Cancer Care0.313891
adjustment disorder0.323889
Palliative Care Editorial0.287821
Cancer Care page0.291913
Care Editorial Board0.290774
anxiety disorders0.412812
stressful event0.352734
fast heart beat0.32985
PDQ summary0.441306
intense anxiety0.302865
cancer clinical trials0.331141
cancer information summaries0.300508
comprehensive cancer information0.300154
cancer0.962959
information0.418397
depression0.295223
CLICK HERE
1938 National Cancer Institute Html es Grados de comprobación científica de los estudios sobre el tratamiento del cáncer en adultos y niños (PDQ®)–Versión para profesionales de salud Información sobre cómo evaluar la solidez de los datos probatorios que se obtienen de diferentes clases de estudios sobre el tratamiento del cáncer.
Visuals Online0.667636
Physician Data Query0.729238
Benhaddad A0.68991
oro —el ensayo0.814208
estadístico kappa0.695883
valoración indirectos0.767699
hipótesis prospectivas explícitas0.790489
amputación vs0.700012
único diseño0.677496
marcadores indirectos0.945889
National Cancer Institute0.71653
alto efectos0.677847
subsequent large randomized0.778241
controlled trials0.698624
Grégoire G0.694845
siguientes riesgos0.670189
valores límite0.703358
Instituto Nacional0.973244
historia clínica0.690891
CLICK HERE
1942 National Cancer Institute Html es Tratamiento de las neoplasias mielodisplásicas o mieloproliferativas (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento de las neoplasias mielodisplásicas o mieloproliferativas, incluso las leucemias mielomonocítica crónica o juvenil y la LMC atípica.
French-American-British Cooperative Leukaemia0.312371
leucemia mieloide0.341853
myelomonocytic leukaemia0.397359
myelomonocytic leukemia with0.326213
platelet-derived growth factor0.354049
with juvenile chronic0.315892
Arber DA0.312178
health organization classification0.3281
Leukemia Group0.315441
genes platelet-derived growth0.312347
with juvenile0.340061
chronic myeloid leukemia0.336615
myelomonocytic leukemia0.944712
leucemia mielomonocítica0.387953
chronic myelomonocytic leukemia0.819447
differentiating myelomonocytic leukemia0.320578
Beran M0.312167
World Health Organization0.355665
neoplasias mielodisplásicas0.314258
stem cell transplantation0.313202
chronic myelogenous leukemia0.364294
Germing U0.362762
myeloproliferative disorders0.313394
cases with chronic0.311538
Leuk Lymphoma0.332534
myelomonocytic leukemia from0.33992
chronic myelomonocytic leukaemia0.386185
juvenile chronic myelogenous0.347073
marrow transplantation0.341155
Organización Mundial0.317633
chronic myeloid0.357031
Differentiating juvenile myelomonocytic0.319715
myeloid neoplasms0.336696
bone marrow transplantation0.325127
Bennett JM0.319603
cromosoma filadelfia0.337822
recuento plaquetario0.325577
juvenile myelomonocytic leukaemia0.339361
juvenile myelomonocytic leukemia0.545157
chronic myeloid leukaemias0.320258
Clin Oncol0.32115
Orazi A0.343564
Cooperative Leukaemia Group0.311788
atypical chronic0.319445
características clínicas0.316309
trastornos mieloides0.311632
leucemia mieloide aguda0.316238
with chronic myelomonocytic0.340508
Emanuel PD0.350668
CLICK HERE
1946 National Cancer Institute Html es Tratamiento del neuroblastoma (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento del neuroblastoma.
glándula tiroides0.633074
posibles efectos tardíos0.641796
siguientes procedimientos0.632822
células madre0.931788
gen alk0.612181
siguientes especialistas0.624871
yodo 131-mibg0.744725
vía oral0.649411
rayos x0.630232
enlace drugs approved0.631928
estadios 2A0.624814
niño ayuda0.632627
ondas sonoras0.629873
riesgo intermedio0.674697
efectos tardíos0.896983
cáncer.ampliar aspiración0.633221
National Cancer Institute0.612675
IRMN).Ampliar Imágenes0.62564
siguientes tratamientos0.624353
menor producción0.628805
Instituto Nacional0.623964
PDQ Tratamiento0.634123
determinados cambios0.611022
alta potencia0.625499
presente sección0.614217
nuevos tipos0.61878
sistema nervioso central0.655496
Physician Data Query0.650241
siguientes pruebas0.680017
siguientes estadios0.629707
siguientes trastornos0.624626
CLICK HERE
2064 National Cancer Institute Html es Exposición al asbesto y el riesgo de cáncer Hoja informativa sobre el asbesto, sobre las enfermedades relacionadas con el asbesto e incluye organizaciones para obtener más información.
técnicos profesionales automotrices0.5421
gen bap10.530949
que familiares de trabajadores0.533144
normas descritas0.532666
largo plazo0.526581
Protección Ambiental0.672505
World Trade Center0.546459
principal dependencia0.532045
Ground Zero0.529197
derrames pleurales benignos0.558277
Salud Ocupacional0.584399
asbesto crisótilo0.987156
trabajadores portuarios0.606054
Instituto Nacional0.563708
menores riesgos0.533274
Trabajo de EE0.535904
Employment Standards Administration0.548898
titulado current best practices0.543841
Mine Safety0.535362
sustancias tóxicas0.635631
siglo xix0.53032
distintos tipos0.525229
Estados Unidos0.992615
automotriz usa0.531695
Public Affairs0.529764
serios problemas0.529441
Environmental Protection Agency0.815767
línea telefónica tsca0.556811
Preventing Asbestos Exposure0.544747
Product Safety Commission0.67091
Information Division0.52746
Occupational Safety0.586355
asbesto causa0.952053
cuánto tiempo0.527545
en la mucosidad0.531534
a las personas0.529484
posibles peligros0.5266
Health Administration0.652906
Consumer Product Safety0.672282
causa dificultad0.530297
sumamente bajo. Los fabricantes0.528798
mejores prácticas0.574094
Clutch Repair Workers0.544379
Veterans Affairs0.528386
Torres Gemelas0.52642
Compensation Programs0.5287
Disease Registry0.526245
Toxic Substances0.526971
Segunda Guerra Mundial0.550565
CLICK HERE
2988 National Cancer Institute Html en Secondhand Smoke Smoking affects both you and your loved one's health. Learn about the consequences of secondhand smoke and how you can protect your family.
feet0.409991
dangers0.420271
Lung cancer0.428942
good example0.428021
non-smoker0.407426
care staff0.426607
nicotine affect0.427281
babysitters0.406286
body0.411562
smoker0.414092
children0.431937
harms0.407652
sure caretakers0.428123
secondhand smoke0.971613
non-smokers0.43912
heart disease‚0.429635
Fact0.410452
short time0.429909
somebody0.406088
health problems0.428728
smokefree restaurants0.432863
lung infections0.428228
smoking indoors0.445671
main way smoking0.477206
Breathing problems0.428866
indoor public places0.450365
babies0.424287
smokers0.419121
air0.417572
life0.412446
Breathing secondhand smoke0.5983
infant death syndrome0.453829
smoking0.508887
National Cancer Institute0.448359
heart attack‚0.429618
kids0.411336
quiz0.411311
cigarette0.405834
coughing‚ extra phlegm‚0.454984
bronchitis0.405901
people0.432125
home0.416331
nannies0.405803
severe attacks0.428972
best thing0.428251
shortness0.406847
ear infections0.428442
low birth weight0.454001
family0.425482
CLICK HERE
15486 National Cancer Institute Html es Delirio ¿Qué es delirio? Delirio es un estado mental confuse. Se explican las causas de delirio, formas de tratarlo y preguntas para hacer al doctor.
delirio hiperactivo0.974791
CLICK HERE
15633 National Cancer Institute Html en Step 1: Application Development & Submission There are nine research grant application types, each with specific procedures. Learn more about developing, submitting, and tracking a cancer research grant application.
small project application0.562018
grant application types0.615791
Funding Opportunity Announcement0.657432
grant applications0.709584
institution business official0.474155
Grants.gov Tracking Number0.523008
ongoing extramural activity0.49934
NIH’s Application0.521892
Grants.gov Registration0.46434
application requirements0.476818
Administrative Supplement Request0.466071
specific receipt date0.531978
grant type0.487204
specific IC program0.505666
peer review processes0.498397
prior approval0.560178
well-defined scientific area0.49086
eRA Commons0.962876
receipt date0.604332
Electronic grant applications0.606906
NIH Guide0.481058
program announcement0.579666
NCI Grant Policies0.586226
sam registration0.473955
scientific peer review0.497797
Small Business Innovation0.484684
application status changes—the0.535723
NCI Funding Opportunities0.538102
NIH0.523095
recent budget project0.476777
Scientific Review Group0.50345
NCI RFA0.467797
application submission deadline0.550381
grant support0.469498
important application basics0.5838
strong application0.469473
application0.872468
application cycles0.489855
final assembled application0.53419
additional prior approval0.492691
grant application0.737304
standing receipt date0.526741
Small Business Technology0.489507
CLICK HERE
16857 National Cancer Institute Html en Prior Approval Requests null
recipient institution0.428349
current policies0.408224
NoA0.327733
NIH recipients0.49032
enforcement action0.408587
latitude0.326586
prior approval requests0.721397
specific prior approval0.686294
grants management specialist0.645519
certain degree0.434218
copies0.318206
prior approval authority0.69999
terms0.318069
prior approval0.984844
unanticipated requirements0.40335
total costs0.405045
Questions0.317851
makes certain budget0.539233
NIH Grants Policy0.559485
limits0.321806
email0.319573
recipient’s discretion0.470347
cc0.322104
termination0.321773
Circumstances0.323427
types0.321678
cases0.320114
subject line0.413724
budget categories0.540205
Statement0.318087
GMO0.360575
disallowance0.318052
grants management officer0.531732
proposed change0.416195
agency authority0.407763
NCI program director0.515619
unauthorized officials0.411596
PD/PI0.318695
undertakes particular activities0.523
expenditures0.324868
response0.318742
post-award changes0.427573
grant number0.410914
unanticipated needs0.427883
responses0.319676
risk0.318261
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.